Explore By Subject Area   
Return Home
Register Now Menu

Chief Medical Officer Summit 360º

Date: Apr 7, 2025 - Apr 8, 2025

Location: Boston, MA

Day 1: Monday, April 07, 2025
Showing Events in 1 Track from 08:00am to 08:20am
Registration Opens Tea/Coffee
8:00AM - 8:20AM
Registration Opens Tea/Coffee
Showing Events in 1 Track from 08:20am to 08:30am
Co-Chairs Opening Remarks
8:20AM - 8:30AM
Co-Chairs Opening Remarks
Co-Chairs:
Anna Frostegård, MD, PhD, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals
Jeff Humphrey, MD, CMO, Lantheus
Showing Events in 1 Track from 08:30am to 09:10am
Morning Keynote
8:30AM - 9:10AM
Annual Keynote Address on the State of the Drug Development Industry
Keynote:
Kenneth Getz, MBA, Executive Director & Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
Showing Events in 1 Track from 09:10am to 09:40am
Policy Keynote
9:10AM - 9:40AM
Policy Keynote with BIO SVP of Federal Government Affairs
Keynote:
Aiken Hackett, Senior Vice President, Federal Government Relations, Biotechnology Innovation Organization
Showing Events in 1 Track from 09:40am to 09:55am
Interactive Networking Session
9:40AM - 9:55AM
Interactive Networking Session
Showing Events in 1 Track from 09:55am to 10:40am
Grand Opening Break & Networking
9:55AM - 10:40AM
Grand Opening Break & Networking
Showing Events in 1 Track from 10:40am to 01:00pm
Morning General Session
10:40AM - 11:10AM
Balancing Simplicity with Complexity in Clinical Trials
Moderated By:
Steve Zelenkofske, DO, President/Principal, SLZ Consulting
Speakers:
Aaron Koenig, MD, CMO, Delix Therapeutics
Christopher Morabito, MD, CMO, Astria Therapeutics
11:10AM - 11:30AM
Leveraging Technology for Physician Oversight in Early Phase Trials
Speaker:
George J. Atiee, MD, Medical Monitor, Dr. Vince Clinical Research
11:30AM - 12:00PM
Utilizing AI to Streamline Clinical Development
Moderated By:
Jeff Humphrey, MD, CMO, Lantheus
Speakers:
Mohammed Asmal, MD, CMO, Prime Medicine
Gen Li, PhD, MBA, President and Founder, Phesi, Inc.
12:00PM - 12:15PM
Reimagining Clinical Trials: How AI and ML Drive Precision, Efficiency and Success
Speaker:
Raviv Pryluk, PhD, CEO & Co-founder, PhaseV
12:15PM - 12:45PM
Power and Pitfalls of Patient Reported Outcome Measures in Clinical Trials
Speaker:
Barry Ticho, MD, PhD, CMO, Stoke Therapeutics, Inc
12:45PM - 1:00PM
How to Measurably Increase Operational Efficiency in Clinical Trials
Speaker:
Julie Martin, MSc, MBA, CEO & Co-Owner, Scimega Research
Showing Events in 1 Track from 01:00pm to 01:55pm
Lunch
1:00PM - 1:55PM
Lunch
Showing Events in 2 Tracks from 02:00pm to 03:35pm
Track 1: Regulatory & Patient Affairs
2:00PM - 2:30PM
How to Better work with CBER and CDER
Moderated By:
Peter Francis, MD, PhD, CMO & CSO, Ray Therapeutics
Panelists:
Alessandra Cesano, MD, PhD, CMO, EVP, ESSA Pharma
Norman Sussman, MD, CMO, DURECT
2:30PM - 2:45PM
Reserved Session
2:45PM - 3:15PM
How to Better Partner with Patient Organizations
Speakers:
Joseph Palumbo, MD, MACPsych, EVP, CMO, Head of R&D, BioVie
Laura Williams, MD, MPH, CMO, Ardelyx
3:15PM - 3:35PM
Navigating Regulatory and Operations Challenges Running Ex-US Trials
Speaker:
Andrea Wang-Gillam, MD, PhD, CMO, Jacobio Pharmaceuticals
Track 2: Medical Affairs & Commercialization
2:00PM - 2:30PM
Bringing Medical Affairs into Clinical Development
Moderated By:
Mark Bach, MD, PhD, CMO, GentiBio
Panelists:
Johan Baeck, MD, EVP, CMO, Promontory Therapeutics Inc.
Peg Crowley-Nowick, PhD, MBA, President, Medical Affairs Consulting and Head of Medical Affairs, Lumanity
Eva Gallagher, PhD, RN, ANP-BC, Vice President, Head of Medical Affairs, Agios Pharmaceuticals
2:30PM - 2:45PM
Reserved Session
2:45PM - 3:15PM
Building a "Triple Threat" Medical Affairs Team
Speakers:
Oliver Rosen, MD, Chief Medical Officer, Akamis Bio
John Yee, MD, MPH, Senior VP, Medical Affairs, Apnimed, Inc.
3:15PM - 3:35PM
Reserved Session
Showing Events in 1 Track from 03:35pm to 04:00pm
Afternoon Break & Networking
3:35PM - 4:00PM
Afternoon Break & Networking
Showing Events in 2 Tracks from 04:05pm to 05:35pm
Track 1: Internal Affairs
4:05PM - 4:35PM
What CEOs Wish CMOs Knew
Moderated By:
Kartik Krishnan, MD, PhD, CEO, OncoNano Medicine
Speakers:
Donna Higgins, CEO, The Higgins Group
Daniela Iwanski, MAOM, Vice President, Executive and Board Recruiting, Govig and Associates
4:35PM - 5:05PM
Building Up a CMO Team as Your Company Evolves
Moderated By:
Harold Bernstein, MD, PhD, MPhil, President, R&D and CMO, Maze Therapeutics
Panelists:
Christophe Arbet-Engels, MD, PhD, CMO, X4 Pharmaceuticals
Dan Bloomfield, MD, CMO, Anthos Therapeutics
Matthew Frankel, MD, CMO, Chemomab Therapeutics
5:05PM - 5:35PM
Working Flexibly with Consultants and Fractional Expertise
Moderated By:
Barbara Troupin, MD, MBA, Fractional CMO, Laguna Bio
Speakers:
Jay Destino, Vice President, Functional Service Provider (FSP) Solutions, BioPoint, Inc.
Steven Katz, MD, CMO and SVP, Translational Research, Shinobi Therapeutics
Michelle Mellion, MD, CMO, PepGen
Track 2: External Affairs
4:05PM - 4:35PM
CRO-Sponsor Best Practices for Project Success
Speaker:
Anna Frostegård, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals
4:35PM - 5:05PM
Ensuring Effective and Efficient Trials Through Clinical Operations
Speakers:
Bruce Dezube, MD, SVP, Clinical Development, Xilio Therapeutics
Roger Waltzman, MD, MBA, CMO, Indaptus Therapeutics
5:05PM - 5:35PM
New Models for Working with Service Providers
Speaker:
Joanne Lager, MD, CMO, NiKang Therapeutics
Abi Vainstein, MD, CMO, Sapience Therapeutics
Showing Events in 1 Track from 05:35pm to 06:35pm
Networking Reception
5:35PM - 6:35PM
Networking Reception
Graciously Hosted By:
Showing Events in 1 Track from 06:35pm to 06:40pm
Day One Ends
6:35PM - 6:40PM
Day One Ends
Showing Events in 1 Track from 08:00am to 08:20am
Registration Opens Tea/Coffee
8:00AM - 8:20AM
Registration Opens Tea/Coffee
Showing Events in 1 Track from 08:20am to 08:30am
Co-Chairs Opening Remarks
8:20AM - 8:30AM
Co-Chairs Opening Remarks
Co-Chairs:
Anna Frostegård, MD, PhD, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals
Jeff Humphrey, MD, CMO, Lantheus
Showing Events in 1 Track from 08:30am to 09:10am
Morning Keynote
8:30AM - 9:10AM
Annual Keynote Address on the State of the Drug Development Industry
Keynote:
Kenneth Getz, MBA, Executive Director & Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
Showing Events in 1 Track from 09:10am to 09:40am
Policy Keynote
9:10AM - 9:40AM
Policy Keynote with BIO SVP of Federal Government Affairs
Keynote:
Aiken Hackett, Senior Vice President, Federal Government Relations, Biotechnology Innovation Organization
Showing Events in 1 Track from 09:40am to 09:55am
Interactive Networking Session
9:40AM - 9:55AM
Interactive Networking Session
Showing Events in 1 Track from 09:55am to 10:40am
Grand Opening Break & Networking
9:55AM - 10:40AM
Grand Opening Break & Networking
Showing Events in 1 Track from 10:40am to 01:00pm
Morning General Session
10:40AM - 11:10AM
Balancing Simplicity with Complexity in Clinical Trials
Moderated By:
Steve Zelenkofske, DO, President/Principal, SLZ Consulting
Speakers:
Aaron Koenig, MD, CMO, Delix Therapeutics
Christopher Morabito, MD, CMO, Astria Therapeutics
11:10AM - 11:30AM
Leveraging Technology for Physician Oversight in Early Phase Trials
Speaker:
George J. Atiee, MD, Medical Monitor, Dr. Vince Clinical Research
11:30AM - 12:00PM
Utilizing AI to Streamline Clinical Development
Moderated By:
Jeff Humphrey, MD, CMO, Lantheus
Speakers:
Mohammed Asmal, MD, CMO, Prime Medicine
Gen Li, PhD, MBA, President and Founder, Phesi, Inc.
12:00PM - 12:15PM
Reimagining Clinical Trials: How AI and ML Drive Precision, Efficiency and Success
Speaker:
Raviv Pryluk, PhD, CEO & Co-founder, PhaseV
12:15PM - 12:45PM
Power and Pitfalls of Patient Reported Outcome Measures in Clinical Trials
Speaker:
Barry Ticho, MD, PhD, CMO, Stoke Therapeutics, Inc
12:45PM - 1:00PM
How to Measurably Increase Operational Efficiency in Clinical Trials
Speaker:
Julie Martin, MSc, MBA, CEO & Co-Owner, Scimega Research
Showing Events in 1 Track from 01:00pm to 01:55pm
Lunch
1:00PM - 1:55PM
Lunch
Showing Events in 2 Tracks from 02:00pm to 03:35pm
Track 1: Regulatory & Patient Affairs
2:00PM - 2:30PM
How to Better work with CBER and CDER
Moderated By:
Peter Francis, MD, PhD, CMO & CSO, Ray Therapeutics
Panelists:
Alessandra Cesano, MD, PhD, CMO, EVP, ESSA Pharma
Norman Sussman, MD, CMO, DURECT
2:30PM - 2:45PM
Reserved Session
2:45PM - 3:15PM
How to Better Partner with Patient Organizations
Speakers:
Joseph Palumbo, MD, MACPsych, EVP, CMO, Head of R&D, BioVie
Laura Williams, MD, MPH, CMO, Ardelyx
3:15PM - 3:35PM
Navigating Regulatory and Operations Challenges Running Ex-US Trials
Speaker:
Andrea Wang-Gillam, MD, PhD, CMO, Jacobio Pharmaceuticals
Track 2: Medical Affairs & Commercialization
2:00PM - 2:30PM
Bringing Medical Affairs into Clinical Development
Moderated By:
Mark Bach, MD, PhD, CMO, GentiBio
Panelists:
Johan Baeck, MD, EVP, CMO, Promontory Therapeutics Inc.
Peg Crowley-Nowick, PhD, MBA, President, Medical Affairs Consulting and Head of Medical Affairs, Lumanity
Eva Gallagher, PhD, RN, ANP-BC, Vice President, Head of Medical Affairs, Agios Pharmaceuticals
2:30PM - 2:45PM
Reserved Session
2:45PM - 3:15PM
Building a "Triple Threat" Medical Affairs Team
Speakers:
Oliver Rosen, MD, Chief Medical Officer, Akamis Bio
John Yee, MD, MPH, Senior VP, Medical Affairs, Apnimed, Inc.
3:15PM - 3:35PM
Reserved Session
Showing Events in 1 Track from 03:35pm to 04:00pm
Afternoon Break & Networking
3:35PM - 4:00PM
Afternoon Break & Networking
Showing Events in 2 Tracks from 04:05pm to 05:35pm
Track 1: Internal Affairs
4:05PM - 4:35PM
What CEOs Wish CMOs Knew
Moderated By:
Kartik Krishnan, MD, PhD, CEO, OncoNano Medicine
Speakers:
Donna Higgins, CEO, The Higgins Group
Daniela Iwanski, MAOM, Vice President, Executive and Board Recruiting, Govig and Associates
4:35PM - 5:05PM
Building Up a CMO Team as Your Company Evolves
Moderated By:
Harold Bernstein, MD, PhD, MPhil, President, R&D and CMO, Maze Therapeutics
Panelists:
Christophe Arbet-Engels, MD, PhD, CMO, X4 Pharmaceuticals
Dan Bloomfield, MD, CMO, Anthos Therapeutics
Matthew Frankel, MD, CMO, Chemomab Therapeutics
5:05PM - 5:35PM
Working Flexibly with Consultants and Fractional Expertise
Moderated By:
Barbara Troupin, MD, MBA, Fractional CMO, Laguna Bio
Speakers:
Jay Destino, Vice President, Functional Service Provider (FSP) Solutions, BioPoint, Inc.
Steven Katz, MD, CMO and SVP, Translational Research, Shinobi Therapeutics
Michelle Mellion, MD, CMO, PepGen
Track 2: External Affairs
4:05PM - 4:35PM
CRO-Sponsor Best Practices for Project Success
Speaker:
Anna Frostegård, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals
4:35PM - 5:05PM
Ensuring Effective and Efficient Trials Through Clinical Operations
Speakers:
Bruce Dezube, MD, SVP, Clinical Development, Xilio Therapeutics
Roger Waltzman, MD, MBA, CMO, Indaptus Therapeutics
5:05PM - 5:35PM
New Models for Working with Service Providers
Speaker:
Joanne Lager, MD, CMO, NiKang Therapeutics
Abi Vainstein, MD, CMO, Sapience Therapeutics
Showing Events in 1 Track from 05:35pm to 06:35pm
Networking Reception
5:35PM - 6:35PM
Networking Reception
Graciously Hosted By:
Showing Events in 1 Track from 06:35pm to 06:40pm
Day One Ends
6:35PM - 6:40PM
Day One Ends
Previous
Day 1
Monday, April 07, 2025

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.